Since BAFF expression in patients’ CSF was closely associated with the relapse of MS or BD (43, 44), it provides a possibility that BAFF may exert a signature on microglial cells during or even before the onset of the diseases. This evidence concerns the gene TNFSF13B and myeloid sarcoma.